Post job

Atara Biotherapeutics's revenue is $128.9 million.

What is Atara Biotherapeutics's revenue?

Atara Biotherapeutics's annual revenue is $128.9M. Zippia's data science team found the following key financial metrics about Atara Biotherapeutics after extensive research and analysis.
  • Atara Biotherapeutics's revenue growth from 2021 to 2024 is 533.92%.
  • Atara Biotherapeutics has 578 employees, and the revenue per employee ratio is $223,079.
  • Atara Biotherapeutics's peak quarterly revenue was $51.6M in 2022(q2).
  • Atara Biotherapeutics peak revenue was $128.9M in 2024.
  • Atara Biotherapeutics annual revenue for 2023 was 8.6M, -86.51% growth from 2022.
  • Atara Biotherapeutics annual revenue for 2024 was 128.9M, 1,404.02% growth from 2023.

On this page

Most recent quarter revenue
$32.8M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$128.9M (2024)
Company peak revenue
Revenue / employee
$223,080
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Most recent quarter revenue
$32.8M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$128.9M (2024)
Company peak revenue
Revenue / employee
$223,080
Company revenue / employee

Atara Biotherapeutics historical revenue

Atara Biotherapeutics's peak revenue was $128.9M in 2024. The peak quarterly revenue was $51.6M in 2022(q2).

Atara Biotherapeutics's revenue increased from $20.3m in 2021 to $128.9M currently. That's a 533.92% change in annual revenue.

Atara Biotherapeutics annual revenue

$129M
$103M
$77M
$52M
$26M
$0
2021
2022
2023
2024

Atara Biotherapeutics annual revenue over time

Fiscal year / yearAtara Biotherapeutics revenue
2021$20.3M
2022$63.6M
2023$8.6M
2024$128.9M

Rate Atara Biotherapeutics' financial transparency

Zippia waving zebra

Atara Biotherapeutics annual growth

Atara Biotherapeutics saw the greatest revenue growth in 2022, when revenue increased by 212.55%.

Atara Biotherapeutics had the lowest revenue growth in 2022, when revenue changed by 212.55%.

Atara Biotherapeutics annual growth rate over time

YearAtara Biotherapeutics growth
2022
213%
2023
-87%
2024
1404%

Atara Biotherapeutics quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$52M
$41M
$31M
$21M
$10M
$0
2021
2022
2023
2024

Atara Biotherapeutics quarterly growth rate over time

YearQ1Q2Q3Q4
2021$3.6M$3.9M$5.4M$7.5M
2022$7.3M$51.6M$4.5M$221,000
2023$1.2M$957,000$2.1M$4.3M
2024$27.4M$28.6M$40.2M$32.8M

Atara Biotherapeutics jobs nearby

Do you work at Atara Biotherapeutics?

Did Atara Biotherapeutics meet its revenue projections?

Atara Biotherapeutics financial information

IndustryPharmaceuticals, Biotechnology & Life Sciences
Company TypePublic
Employees Number578
Date Founded2012
HeadquartersSouth San Francisco, California
Number of Locations6
Revenue$128.9M
Net Income-$228,302,000
Gross Proft$107.9M (2024)
PE Ratio-5.43
Tax Rate0.0%
Market Capitalization$463.7M
Total Assets$376,420,000
TickerATRA

Atara Biotherapeutics jobs you might like

Atara Biotherapeutics financing

Atara Biotherapeutics received early financing of $1.0M on 2013-03-31.

SeriesRound sizeDate
Series Unknown$1M03/2013
Series B$38.5M12/2013
Series B$13.5M01/2014
Series Unknown$6.3M01/2014

Atara Biotherapeutics investors

InvestorsSecurity type
Domain AssociatesSeries Unknown
Alexandria VentureSeries B
EcoR1 Capital LLCSeries B
CELGENE CORP DESeries B
DAG VenturesSeries B
Kleiner PerkinsSeries B
Amgen Inc.Series B
Domain AssociatesSeries B
Alexandria VentureSeries B
EcoR1 Capital LLCSeries B
CELGENE CORP DESeries B
DAG VenturesSeries B
Kleiner PerkinsSeries B
Amgen Inc.Series B
Domain AssociatesSeries B

Atara Biotherapeutics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Atara Biotherapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Atara Biotherapeutics. The employee data is based on information from people who have self-reported their past or current employments at Atara Biotherapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Atara Biotherapeutics. The data presented on this page does not represent the view of Atara Biotherapeutics and its employees or that of Zippia.

Atara Biotherapeutics may also be known as or be related to ATARA BIOTHERAPEUTICS INC., Atara Biotherapeutics, Atara Biotherapeutics Inc and Atara Biotherapeutics, Inc.